8-K - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Filer)
Teva Pharmaceutical Industries Ltd（CIK: 0000818686）于2026年10月29日提交8-K，报告期为2026年10月27日，涉及Item 5.02：董事或部分高管离任、董事选举、部分高管任命及薪酬安排。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-29
Accepted
2026-10-29 17:08:32
Documents
9
Period of Report
2026-10-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | 8-K | teva-20261027.htm iXBRL | 8-K | 59816 |
| Complete submission text file | 0001193125-26-438019.txt | 170434 |
Data Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 2 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | teva-20261027.xsd | EX-101.SCH | 29640 |
| 12 | EXTRACTED XBRL INSTANCE DOCUMENT | teva-20261027_htm.xml | XML | 4553 |
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV Israel
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV Israel 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)
EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 261502808
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov